1 Study Coverage 1.1 Erectile Dysfunction Drugs Product Introduction 1.2 Market by Type 1.2.1 Global Erectile Dysfunction Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Sildenafil 1.2.3 Tadalafil 1.2.4 Others 1.3 Market by Application 1.3.1 Global Erectile Dysfunction Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Hospital Pharmacies 1.3.3 Private Clinics 1.3.4 Retail Pharmacies 1.3.5 E-Commerce (B2B) 1.3.6 E-Commerce (B2C) 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Erectile Dysfunction Drugs Sales Estimates and Forecasts 2017-2028 2.2 Global Erectile Dysfunction Drugs Revenue Estimates and Forecasts 2017-2028 2.3 Global Erectile Dysfunction Drugs Revenue by Region: 2017 VS 2021 VS 2028 2.4 Global Erectile Dysfunction Drugs Sales by Region 2.4.1 Global Erectile Dysfunction Drugs Sales by Region (2017-2022) 2.4.2 Global Sales Erectile Dysfunction Drugs by Region (2023-2028) 2.5 Global Erectile Dysfunction Drugs Revenue by Region 2.5.1 Global Erectile Dysfunction Drugs Revenue by Region (2017-2022) 2.5.2 Global Erectile Dysfunction Drugs Revenue by Region (2023-2028) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa 3 Competition by Manufacturers 3.1 Global Erectile Dysfunction Drugs Sales by Manufacturers 3.1.1 Global Top Erectile Dysfunction Drugs Manufacturers by Sales (2017-2022) 3.1.2 Global Erectile Dysfunction Drugs Sales Market Share by Manufacturers (2017-2022) 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Erectile Dysfunction Drugs in 2021 3.2 Global Erectile Dysfunction Drugs Revenue by Manufacturers 3.2.1 Global Erectile Dysfunction Drugs Revenue by Manufacturers (2017-2022) 3.2.2 Global Erectile Dysfunction Drugs Revenue Market Share by Manufacturers (2017-2022) 3.2.3 Global Top 10 and Top 5 Companies by Erectile Dysfunction Drugs Revenue in 2021 3.3 Global Erectile Dysfunction Drugs Sales Price by Manufacturers (2017-2022) 3.4 Analysis of Competitive Landscape 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Erectile Dysfunction Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4.3 Global Erectile Dysfunction Drugs Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global Erectile Dysfunction Drugs Sales by Type 4.1.1 Global Erectile Dysfunction Drugs Historical Sales by Type (2017-2022) 4.1.2 Global Erectile Dysfunction Drugs Forecasted Sales by Type (2023-2028) 4.1.3 Global Erectile Dysfunction Drugs Sales Market Share by Type (2017-2028) 4.2 Global Erectile Dysfunction Drugs Revenue by Type 4.2.1 Global Erectile Dysfunction Drugs Historical Revenue by Type (2017-2022) 4.2.2 Global Erectile Dysfunction Drugs Forecasted Revenue by Type (2023-2028) 4.2.3 Global Erectile Dysfunction Drugs Revenue Market Share by Type (2017-2028) 4.3 Global Erectile Dysfunction Drugs Price by Type 4.3.1 Global Erectile Dysfunction Drugs Price by Type (2017-2022) 4.3.2 Global Erectile Dysfunction Drugs Price Forecast by Type (2023-2028) 5 Market Size by Application 5.1 Global Erectile Dysfunction Drugs Sales by Application 5.1.1 Global Erectile Dysfunction Drugs Historical Sales by Application (2017-2022) 5.1.2 Global Erectile Dysfunction Drugs Forecasted Sales by Application (2023-2028) 5.1.3 Global Erectile Dysfunction Drugs Sales Market Share by Application (2017-2028) 5.2 Global Erectile Dysfunction Drugs Revenue by Application 5.2.1 Global Erectile Dysfunction Drugs Historical Revenue by Application (2017-2022) 5.2.2 Global Erectile Dysfunction Drugs Forecasted Revenue by Application (2023-2028) 5.2.3 Global Erectile Dysfunction Drugs Revenue Market Share by Application (2017-2028) 5.3 Global Erectile Dysfunction Drugs Price by Application 5.3.1 Global Erectile Dysfunction Drugs Price by Application (2017-2022) 5.3.2 Global Erectile Dysfunction Drugs Price Forecast by Application (2023-2028) 6 North America 6.1 North America Erectile Dysfunction Drugs Market Size by Type 6.1.1 North America Erectile Dysfunction Drugs Sales by Type (2017-2028) 6.1.2 North America Erectile Dysfunction Drugs Revenue by Type (2017-2028) 6.2 North America Erectile Dysfunction Drugs Market Size by Application 6.2.1 North America Erectile Dysfunction Drugs Sales by Application (2017-2028) 6.2.2 North America Erectile Dysfunction Drugs Revenue by Application (2017-2028) 6.3 North America Erectile Dysfunction Drugs Market Size by Country 6.3.1 North America Erectile Dysfunction Drugs Sales by Country (2017-2028) 6.3.2 North America Erectile Dysfunction Drugs Revenue by Country (2017-2028) 6.3.3 U.S. 6.3.4 Canada 7 Europe 7.1 Europe Erectile Dysfunction Drugs Market Size by Type 7.1.1 Europe Erectile Dysfunction Drugs Sales by Type (2017-2028) 7.1.2 Europe Erectile Dysfunction Drugs Revenue by Type (2017-2028) 7.2 Europe Erectile Dysfunction Drugs Market Size by Application 7.2.1 Europe Erectile Dysfunction Drugs Sales by Application (2017-2028) 7.2.2 Europe Erectile Dysfunction Drugs Revenue by Application (2017-2028) 7.3 Europe Erectile Dysfunction Drugs Market Size by Country 7.3.1 Europe Erectile Dysfunction Drugs Sales by Country (2017-2028) 7.3.2 Europe Erectile Dysfunction Drugs Revenue by Country (2017-2028) 7.3.3 Germany 7.3.4 France 7.3.5 U.K. 7.3.6 Italy 7.3.7 Russia 8 Asia Pacific 8.1 Asia Pacific Erectile Dysfunction Drugs Market Size by Type 8.1.1 Asia Pacific Erectile Dysfunction Drugs Sales by Type (2017-2028) 8.1.2 Asia Pacific Erectile Dysfunction Drugs Revenue by Type (2017-2028) 8.2 Asia Pacific Erectile Dysfunction Drugs Market Size by Application 8.2.1 Asia Pacific Erectile Dysfunction Drugs Sales by Application (2017-2028) 8.2.2 Asia Pacific Erectile Dysfunction Drugs Revenue by Application (2017-2028) 8.3 Asia Pacific Erectile Dysfunction Drugs Market Size by Region 8.3.1 Asia Pacific Erectile Dysfunction Drugs Sales by Region (2017-2028) 8.3.2 Asia Pacific Erectile Dysfunction Drugs Revenue by Region (2017-2028) 8.3.3 China 8.3.4 Japan 8.3.5 South Korea 8.3.6 India 8.3.7 Australia 8.3.8 China Taiwan 8.3.9 Indonesia 8.3.10 Thailand 8.3.11 Malaysia 9 Latin America 9.1 Latin America Erectile Dysfunction Drugs Market Size by Type 9.1.1 Latin America Erectile Dysfunction Drugs Sales by Type (2017-2028) 9.1.2 Latin America Erectile Dysfunction Drugs Revenue by Type (2017-2028) 9.2 Latin America Erectile Dysfunction Drugs Market Size by Application 9.2.1 Latin America Erectile Dysfunction Drugs Sales by Application (2017-2028) 9.2.2 Latin America Erectile Dysfunction Drugs Revenue by Application (2017-2028) 9.3 Latin America Erectile Dysfunction Drugs Market Size by Country 9.3.1 Latin America Erectile Dysfunction Drugs Sales by Country (2017-2028) 9.3.2 Latin America Erectile Dysfunction Drugs Revenue by Country (2017-2028) 9.3.3 Mexico 9.3.4 Brazil 9.3.5 Argentina 10 Middle East and Africa 10.1 Middle East and Africa Erectile Dysfunction Drugs Market Size by Type 10.1.1 Middle East and Africa Erectile Dysfunction Drugs Sales by Type (2017-2028) 10.1.2 Middle East and Africa Erectile Dysfunction Drugs Revenue by Type (2017-2028) 10.2 Middle East and Africa Erectile Dysfunction Drugs Market Size by Application 10.2.1 Middle East and Africa Erectile Dysfunction Drugs Sales by Application (2017-2028) 10.2.2 Middle East and Africa Erectile Dysfunction Drugs Revenue by Application (2017-2028) 10.3 Middle East and Africa Erectile Dysfunction Drugs Market Size by Country 10.3.1 Middle East and Africa Erectile Dysfunction Drugs Sales by Country (2017-2028) 10.3.2 Middle East and Africa Erectile Dysfunction Drugs Revenue by Country (2017-2028) 10.3.3 Turkey 10.3.4 Saudi Arabia 11 Company Profiles 11.1 Eli Lilly 11.1.1 Eli Lilly Corporation Information 11.1.2 Eli Lilly Overview 11.1.3 Eli Lilly Erectile Dysfunction Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.1.4 Eli Lilly Erectile Dysfunction Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.1.5 Eli Lilly Recent Developments 11.2 Pfizer 11.2.1 Pfizer Corporation Information 11.2.2 Pfizer Overview 11.2.3 Pfizer Erectile Dysfunction Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.2.4 Pfizer Erectile Dysfunction Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.2.5 Pfizer Recent Developments 11.3 Bayer 11.3.1 Bayer Corporation Information 11.3.2 Bayer Overview 11.3.3 Bayer Erectile Dysfunction Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.3.4 Bayer Erectile Dysfunction Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.3.5 Bayer Recent Developments 11.4 BaiYunShan General Factory 11.4.1 BaiYunShan General Factory Corporation Information 11.4.2 BaiYunShan General Factory Overview 11.4.3 BaiYunShan General Factory Erectile Dysfunction Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.4.4 BaiYunShan General Factory Erectile Dysfunction Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.4.5 BaiYunShan General Factory Recent Developments 11.5 S.K. Chemicals 11.5.1 S.K. Chemicals Corporation Information 11.5.2 S.K. Chemicals Overview 11.5.3 S.K. Chemicals Erectile Dysfunction Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.5.4 S.K. Chemicals Erectile Dysfunction Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.5.5 S.K. Chemicals Recent Developments 11.6 Teva Pharma 11.6.1 Teva Pharma Corporation Information 11.6.2 Teva Pharma Overview 11.6.3 Teva Pharma Erectile Dysfunction Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.6.4 Teva Pharma Erectile Dysfunction Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.6.5 Teva Pharma Recent Developments 11.7 Dong-A ST 11.7.1 Dong-A ST Corporation Information 11.7.2 Dong-A ST Overview 11.7.3 Dong-A ST Erectile Dysfunction Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.7.4 Dong-A ST Erectile Dysfunction Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.7.5 Dong-A ST Recent Developments 11.8 Metuchen Pharma 11.8.1 Metuchen Pharma Corporation Information 11.8.2 Metuchen Pharma Overview 11.8.3 Metuchen Pharma Erectile Dysfunction Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.8.4 Metuchen Pharma Erectile Dysfunction Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.8.5 Metuchen Pharma Recent Developments 11.9 Seoul Pharma 11.9.1 Seoul Pharma Corporation Information 11.9.2 Seoul Pharma Overview 11.9.3 Seoul Pharma Erectile Dysfunction Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.9.4 Seoul Pharma Erectile Dysfunction Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.9.5 Seoul Pharma Recent Developments 11.10 CSBIO. 11.10.1 CSBIO. Corporation Information 11.10.2 CSBIO. Overview 11.10.3 CSBIO. Erectile Dysfunction Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.10.4 CSBIO. Erectile Dysfunction Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.10.5 CSBIO. Recent Developments 12 Industry Chain and Sales Channels Analysis 12.1 Erectile Dysfunction Drugs Industry Chain Analysis 12.2 Erectile Dysfunction Drugs Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Erectile Dysfunction Drugs Production Mode & Process 12.4 Erectile Dysfunction Drugs Sales and Marketing 12.4.1 Erectile Dysfunction Drugs Sales Channels 12.4.2 Erectile Dysfunction Drugs Distributors 12.5 Erectile Dysfunction Drugs Customers 13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 Erectile Dysfunction Drugs Industry Trends 13.2 Erectile Dysfunction Drugs Market Drivers 13.3 Erectile Dysfunction Drugs Market Challenges 13.4 Erectile Dysfunction Drugs Market Restraints 14 Key Findings in The Global Erectile Dysfunction Drugs Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer

List of Tables Table 1. Global Erectile Dysfunction Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million) Table 2. Major Manufacturers of Sildenafil Table 3. Major Manufacturers of Tadalafil Table 4. Major Manufacturers of Others Table 5. Global Erectile Dysfunction Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million) Table 6. Global Erectile Dysfunction Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million) Table 7. Global Erectile Dysfunction Drugs Sales by Region (2017-2022) & (M Pill) Table 8. Global Erectile Dysfunction Drugs Sales Market Share by Region (2017-2022) Table 9. Global Erectile Dysfunction Drugs Sales by Region (2023-2028) & (M Pill) Table 10. Global Erectile Dysfunction Drugs Sales Market Share by Region (2023-2028) Table 11. Global Erectile Dysfunction Drugs Revenue by Region (2017-2022) & (US$ Million) Table 12. Global Erectile Dysfunction Drugs Revenue Market Share by Region (2017-2022) Table 13. Global Erectile Dysfunction Drugs Revenue by Region (2023-2028) & (US$ Million) Table 14. Global Erectile Dysfunction Drugs Revenue Market Share by Region (2023-2028) Table 15. Global Erectile Dysfunction Drugs Sales by Manufacturers (2017-2022) & (M Pill) Table 16. Global Erectile Dysfunction Drugs Sales Share by Manufacturers (2017-2022) Table 17. Global Erectile Dysfunction Drugs Revenue by Manufacturers (2017-2022) & (US$ Million) Table 18. Global Erectile Dysfunction Drugs Revenue Share by Manufacturers (2017-2022) Table 19. Erectile Dysfunction Drugs Price by Manufacturers (2017-2022) &(USD/Pill) Table 20. Global Erectile Dysfunction Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) Table 21. Global Erectile Dysfunction Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Erectile Dysfunction Drugs as of 2021) Table 22. Erectile Dysfunction Drugs Manufacturing Base Distribution and Headquarters Table 23. Manufacturers Erectile Dysfunction Drugs Product Offered Table 24. Date of Manufacturers Enter into Erectile Dysfunction Drugs Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Erectile Dysfunction Drugs Sales by Type (2017-2022) & (M Pill) Table 27. Global Erectile Dysfunction Drugs Sales by Type (2023-2028) & (M Pill) Table 28. Global Erectile Dysfunction Drugs Sales Share by Type (2017-2022) Table 29. Global Erectile Dysfunction Drugs Sales Share by Type (2023-2028) Table 30. Global Erectile Dysfunction Drugs Revenue by Type (2017-2022) & (US$ Million) Table 31. Global Erectile Dysfunction Drugs Revenue by Type (2023-2028) & (US$ Million) Table 32. Global Erectile Dysfunction Drugs Revenue Share by Type (2017-2022) Table 33. Global Erectile Dysfunction Drugs Revenue Share by Type (2023-2028) Table 34. Erectile Dysfunction Drugs Price by Type (2017-2022) & (USD/Pill) Table 35. Global Erectile Dysfunction Drugs Price Forecast by Type (2023-2028) & (USD/Pill) Table 36. Global Erectile Dysfunction Drugs Sales by Application (2017-2022) & (M Pill) Table 37. Global Erectile Dysfunction Drugs Sales by Application (2023-2028) & (M Pill) Table 38. Global Erectile Dysfunction Drugs Sales Share by Application (2017-2022) Table 39. Global Erectile Dysfunction Drugs Sales Share by Application (2023-2028) Table 40. Global Erectile Dysfunction Drugs Revenue by Application (2017-2022) & (US$ Million) Table 41. Global Erectile Dysfunction Drugs Revenue by Application (2023-2028) & (US$ Million) Table 42. Global Erectile Dysfunction Drugs Revenue Share by Application (2017-2022) Table 43. Global Erectile Dysfunction Drugs Revenue Share by Application (2023-2028) Table 44. Erectile Dysfunction Drugs Price by Application (2017-2022) & (USD/Pill) Table 45. Global Erectile Dysfunction Drugs Price Forecast by Application (2023-2028) & (USD/Pill) Table 46. North America Erectile Dysfunction Drugs Sales by Type (2017-2022) & (M Pill) Table 47. North America Erectile Dysfunction Drugs Sales by Type (2023-2028) & (M Pill) Table 48. North America Erectile Dysfunction Drugs Revenue by Type (2017-2022) & (US$ Million) Table 49. North America Erectile Dysfunction Drugs Revenue by Type (2023-2028) & (US$ Million) Table 50. North America Erectile Dysfunction Drugs Sales by Application (2017-2022) & (M Pill) Table 51. North America Erectile Dysfunction Drugs Sales by Application (2023-2028) & (M Pill) Table 52. North America Erectile Dysfunction Drugs Revenue by Application (2017-2022) & (US$ Million) Table 53. North America Erectile Dysfunction Drugs Revenue by Application (2023-2028) & (US$ Million) Table 54. North America Erectile Dysfunction Drugs Sales by Country (2017-2022) & (M Pill) Table 55. North America Erectile Dysfunction Drugs Sales by Country (2023-2028) & (M Pill) Table 56. North America Erectile Dysfunction Drugs Revenue by Country (2017-2022) & (US$ Million) Table 57. North America Erectile Dysfunction Drugs Revenue by Country (2023-2028) & (US$ Million) Table 58. Europe Erectile Dysfunction Drugs Sales by Type (2017-2022) & (M Pill) Table 59. Europe Erectile Dysfunction Drugs Sales by Type (2023-2028) & (M Pill) Table 60. Europe Erectile Dysfunction Drugs Revenue by Type (2017-2022) & (US$ Million) Table 61. Europe Erectile Dysfunction Drugs Revenue by Type (2023-2028) & (US$ Million) Table 62. Europe Erectile Dysfunction Drugs Sales by Application (2017-2022) & (M Pill) Table 63. Europe Erectile Dysfunction Drugs Sales by Application (2023-2028) & (M Pill) Table 64. Europe Erectile Dysfunction Drugs Revenue by Application (2017-2022) & (US$ Million) Table 65. Europe Erectile Dysfunction Drugs Revenue by Application (2023-2028) & (US$ Million) Table 66. Europe Erectile Dysfunction Drugs Sales by Country (2017-2022) & (M Pill) Table 67. Europe Erectile Dysfunction Drugs Sales by Country (2023-2028) & (M Pill) Table 68. Europe Erectile Dysfunction Drugs Revenue by Country (2017-2022) & (US$ Million) Table 69. Europe Erectile Dysfunction Drugs Revenue by Country (2023-2028) & (US$ Million) Table 70. Asia Pacific Erectile Dysfunction Drugs Sales by Type (2017-2022) & (M Pill) Table 71. Asia Pacific Erectile Dysfunction Drugs Sales by Type (2023-2028) & (M Pill) Table 72. Asia Pacific Erectile Dysfunction Drugs Revenue by Type (2017-2022) & (US$ Million) Table 73. Asia Pacific Erectile Dysfunction Drugs Revenue by Type (2023-2028) & (US$ Million) Table 74. Asia Pacific Erectile Dysfunction Drugs Sales by Application (2017-2022) & (M Pill) Table 75. Asia Pacific Erectile Dysfunction Drugs Sales by Application (2023-2028) & (M Pill) Table 76. Asia Pacific Erectile Dysfunction Drugs Revenue by Application (2017-2022) & (US$ Million) Table 77. Asia Pacific Erectile Dysfunction Drugs Revenue by Application (2023-2028) & (US$ Million) Table 78. Asia Pacific Erectile Dysfunction Drugs Sales by Region (2017-2022) & (M Pill) Table 79. Asia Pacific Erectile Dysfunction Drugs Sales by Region (2023-2028) & (M Pill) Table 80. Asia Pacific Erectile Dysfunction Drugs Revenue by Region (2017-2022) & (US$ Million) Table 81. Asia Pacific Erectile Dysfunction Drugs Revenue by Region (2023-2028) & (US$ Million) Table 82. Latin America Erectile Dysfunction Drugs Sales by Type (2017-2022) & (M Pill) Table 83. Latin America Erectile Dysfunction Drugs Sales by Type (2023-2028) & (M Pill) Table 84. Latin America Erectile Dysfunction Drugs Revenue by Type (2017-2022) & (US$ Million) Table 85. Latin America Erectile Dysfunction Drugs Revenue by Type (2023-2028) & (US$ Million) Table 86. Latin America Erectile Dysfunction Drugs Sales by Application (2017-2022) & (M Pill) Table 87. Latin America Erectile Dysfunction Drugs Sales by Application (2023-2028) & (M Pill) Table 88. Latin America Erectile Dysfunction Drugs Revenue by Application (2017-2022) & (US$ Million) Table 89. Latin America Erectile Dysfunction Drugs Revenue by Application (2023-2028) & (US$ Million) Table 90. Latin America Erectile Dysfunction Drugs Sales by Country (2017-2022) & (M Pill) Table 91. Latin America Erectile Dysfunction Drugs Sales by Country (2023-2028) & (M Pill) Table 92. Latin America Erectile Dysfunction Drugs Revenue by Country (2017-2022) & (US$ Million) Table 93. Latin America Erectile Dysfunction Drugs Revenue by Country (2023-2028) & (US$ Million) Table 94. Middle East and Africa Erectile Dysfunction Drugs Sales by Type (2017-2022) & (M Pill) Table 95. Middle East and Africa Erectile Dysfunction Drugs Sales by Type (2023-2028) & (M Pill) Table 96. Middle East and Africa Erectile Dysfunction Drugs Revenue by Type (2017-2022) & (US$ Million) Table 97. Middle East and Africa Erectile Dysfunction Drugs Revenue by Type (2023-2028) & (US$ Million) Table 98. Middle East and Africa Erectile Dysfunction Drugs Sales by Application (2017-2022) & (M Pill) Table 99. Middle East and Africa Erectile Dysfunction Drugs Sales by Application (2023-2028) & (M Pill) Table 100. Middle East and Africa Erectile Dysfunction Drugs Revenue by Application (2017-2022) & (US$ Million) Table 101. Middle East and Africa Erectile Dysfunction Drugs Revenue by Application (2023-2028) & (US$ Million) Table 102. Middle East and Africa Erectile Dysfunction Drugs Sales by Country (2017-2022) & (M Pill) Table 103. Middle East and Africa Erectile Dysfunction Drugs Sales by Country (2023-2028) & (M Pill) Table 104. Middle East and Africa Erectile Dysfunction Drugs Revenue by Country (2017-2022) & (US$ Million) Table 105. Middle East and Africa Erectile Dysfunction Drugs Revenue by Country (2023-2028) & (US$ Million) Table 106. Eli Lilly Corporation Information Table 107. Eli Lilly Description and Major Businesses Table 108. Eli Lilly Erectile Dysfunction Drugs Sales (M Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2017-2022) Table 109. Eli Lilly Erectile Dysfunction Drugs Product Model Numbers, Pictures, Descriptions and Specifications Table 110. Eli Lilly Recent Developments Table 111. Pfizer Corporation Information Table 112. Pfizer Description and Major Businesses Table 113. Pfizer Erectile Dysfunction Drugs Sales (M Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2017-2022) Table 114. Pfizer Erectile Dysfunction Drugs Product Model Numbers, Pictures, Descriptions and Specifications Table 115. Pfizer Recent Developments Table 116. Bayer Corporation Information Table 117. Bayer Description and Major Businesses Table 118. Bayer Erectile Dysfunction Drugs Sales (M Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2017-2022) Table 119. Bayer Erectile Dysfunction Drugs Product Model Numbers, Pictures, Descriptions and Specifications Table 120. Bayer Recent Developments Table 121. BaiYunShan General Factory Corporation Information Table 122. BaiYunShan General Factory Description and Major Businesses Table 123. BaiYunShan General Factory Erectile Dysfunction Drugs Sales (M Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2017-2022) Table 124. BaiYunShan General Factory Erectile Dysfunction Drugs Product Model Numbers, Pictures, Descriptions and Specifications Table 125. BaiYunShan General Factory Recent Developments Table 126. S.K. Chemicals Corporation Information Table 127. S.K. Chemicals Description and Major Businesses Table 128. S.K. Chemicals Erectile Dysfunction Drugs Sales (M Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2017-2022) Table 129. S.K. Chemicals Erectile Dysfunction Drugs Product Model Numbers, Pictures, Descriptions and Specifications Table 130. S.K. Chemicals Recent Developments Table 131. Teva Pharma Corporation Information Table 132. Teva Pharma Description and Major Businesses Table 133. Teva Pharma Erectile Dysfunction Drugs Sales (M Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2017-2022) Table 134. Teva Pharma Erectile Dysfunction Drugs Product Model Numbers, Pictures, Descriptions and Specifications Table 135. Teva Pharma Recent Developments Table 136. Dong-A ST Corporation Information Table 137. Dong-A ST Description and Major Businesses Table 138. Dong-A ST Erectile Dysfunction Drugs Sales (M Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2017-2022) Table 139. Dong-A ST Erectile Dysfunction Drugs Product Model Numbers, Pictures, Descriptions and Specifications Table 140. Dong-A ST Recent Developments Table 141. Metuchen Pharma Corporation Information Table 142. Metuchen Pharma Description and Major Businesses Table 143. Metuchen Pharma Erectile Dysfunction Drugs Sales (M Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2017-2022) Table 144. Metuchen Pharma Erectile Dysfunction Drugs Product Model Numbers, Pictures, Descriptions and Specifications Table 145. Metuchen Pharma Recent Developments Table 146. Seoul Pharma Corporation Information Table 147. Seoul Pharma Description and Major Businesses Table 148. Seoul Pharma Erectile Dysfunction Drugs Sales (M Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2017-2022) Table 149. Seoul Pharma Erectile Dysfunction Drugs Product Model Numbers, Pictures, Descriptions and Specifications Table 150. Seoul Pharma Recent Developments Table 151. CSBIO. Corporation Information Table 152. CSBIO. Description and Major Businesses Table 153. CSBIO. Erectile Dysfunction Drugs Sales (M Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2017-2022) Table 154. CSBIO. Erectile Dysfunction Drugs Product Model Numbers, Pictures, Descriptions and Specifications Table 155. CSBIO. Recent Developments Table 156. Key Raw Materials Lists Table 157. Raw Materials Key Suppliers Lists Table 158. Erectile Dysfunction Drugs Distributors List Table 159. Erectile Dysfunction Drugs Customers List Table 160. Erectile Dysfunction Drugs Market Trends Table 161. Erectile Dysfunction Drugs Market Drivers Table 162. Erectile Dysfunction Drugs Market Challenges Table 163. Erectile Dysfunction Drugs Market Restraints Table 164. Research Programs/Design for This Report Table 165. Key Data Information from Secondary Sources Table 166. Key Data Information from Primary Sources List of Figures Figure 1. Erectile Dysfunction Drugs Product Picture Figure 3. Global Erectile Dysfunction Drugs Market Share by Type in 2021 & 2028 Figure 3. Sildenafil Product Picture Figure 4. Tadalafil Product Picture Figure 5. Others Product Picture Figure 6. Global Erectile Dysfunction Drugs Market Share by Application in 2021 & 2028 Figure 7. Hospital Pharmacies Figure 8. Private Clinics Figure 9. Retail Pharmacies Figure 10. E-Commerce (B2B) Figure 11. E-Commerce (B2C) Figure 12. Erectile Dysfunction Drugs Report Years Considered Figure 13. Global Erectile Dysfunction Drugs Sales 2017-2028 (M Pill) Figure 14. Global Erectile Dysfunction Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 15. Global Erectile Dysfunction Drugs Revenue 2017-2028 (US$ Million) Figure 16. Global Erectile Dysfunction Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028 Figure 17. Global Erectile Dysfunction Drugs Sales Market Share by Region (2017-2022) Figure 18. Global Erectile Dysfunction Drugs Sales Market Share by Region (2023-2028) Figure 19. North America Erectile Dysfunction Drugs Sales YoY (2017-2028) & (M Pill) Figure 20. North America Erectile Dysfunction Drugs Revenue YoY (2017-2028) & (US$ Million) Figure 21. Europe Erectile Dysfunction Drugs Sales YoY (2017-2028) & (M Pill) Figure 22. Europe Erectile Dysfunction Drugs Revenue YoY (2017-2028) & (US$ Million) Figure 23. Asia-Pacific Erectile Dysfunction Drugs Sales YoY (2017-2028) & (M Pill) Figure 24. Asia-Pacific Erectile Dysfunction Drugs Revenue YoY (2017-2028) & (US$ Million) Figure 25. Latin America Erectile Dysfunction Drugs Sales YoY (2017-2028) & (M Pill) Figure 26. Latin America Erectile Dysfunction Drugs Revenue YoY (2017-2028) & (US$ Million) Figure 27. Middle East & Africa Erectile Dysfunction Drugs Sales YoY (2017-2028) & (M Pill) Figure 28. Middle East & Africa Erectile Dysfunction Drugs Revenue YoY (2017-2028) & (US$ Million) Figure 29. The Erectile Dysfunction Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021 Figure 30. The Top 5 and 10 Largest Manufacturers of Erectile Dysfunction Drugs in the World: Market Share by Erectile Dysfunction Drugs Revenue in 2021 Figure 31. Global Erectile Dysfunction Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021 Figure 32. Global Erectile Dysfunction Drugs Sales Market Share by Type (2017-2028) Figure 33. Global Erectile Dysfunction Drugs Revenue Market Share by Type (2017-2028) Figure 34. Global Erectile Dysfunction Drugs Sales Market Share by Application (2017-2028) Figure 35. Global Erectile Dysfunction Drugs Revenue Market Share by Application (2017-2028) Figure 36. North America Erectile Dysfunction Drugs Sales Market Share by Type (2017-2028) Figure 37. North America Erectile Dysfunction Drugs Revenue Market Share by Type (2017-2028) Figure 38. North America Erectile Dysfunction Drugs Sales Market Share by Application (2017-2028) Figure 39. North America Erectile Dysfunction Drugs Revenue Market Share by Application (2017-2028) Figure 40. North America Erectile Dysfunction Drugs Sales Share by Country (2017-2028) Figure 41. North America Erectile Dysfunction Drugs Revenue Share by Country (2017-2028) Figure 42. U.S. Erectile Dysfunction Drugs Revenue (2017-2028) & (US$ Million) Figure 43. Canada Erectile Dysfunction Drugs Revenue (2017-2028) & (US$ Million) Figure 44. Europe Erectile Dysfunction Drugs Sales Market Share by Type (2017-2028) Figure 45. Europe Erectile Dysfunction Drugs Revenue Market Share by Type (2017-2028) Figure 46. Europe Erectile Dysfunction Drugs Sales Market Share by Application (2017-2028) Figure 47. Europe Erectile Dysfunction Drugs Revenue Market Share by Application (2017-2028) Figure 48. Europe Erectile Dysfunction Drugs Sales Share by Country (2017-2028) Figure 49. Europe Erectile Dysfunction Drugs Revenue Share by Country (2017-2028) Figure 50. Germany Erectile Dysfunction Drugs Revenue (2017-2028) & (US$ Million) Figure 51. France Erectile Dysfunction Drugs Revenue (2017-2028) & (US$ Million) Figure 52. U.K. Erectile Dysfunction Drugs Revenue (2017-2028) & (US$ Million) Figure 53. Italy Erectile Dysfunction Drugs Revenue (2017-2028) & (US$ Million) Figure 54. Russia Erectile Dysfunction Drugs Revenue (2017-2028) & (US$ Million) Figure 55. Asia Pacific Erectile Dysfunction Drugs Sales Market Share by Type (2017-2028) Figure 56. Asia Pacific Erectile Dysfunction Drugs Revenue Market Share by Type (2017-2028) Figure 57. Asia Pacific Erectile Dysfunction Drugs Sales Market Share by Application (2017-2028) Figure 58. Asia Pacific Erectile Dysfunction Drugs Revenue Market Share by Application (2017-2028) Figure 59. Asia Pacific Erectile Dysfunction Drugs Sales Share by Region (2017-2028) Figure 60. Asia Pacific Erectile Dysfunction Drugs Revenue Share by Region (2017-2028) Figure 61. China Erectile Dysfunction Drugs Revenue (2017-2028) & (US$ Million) Figure 62. Japan Erectile Dysfunction Drugs Revenue (2017-2028) & (US$ Million) Figure 63. South Korea Erectile Dysfunction Drugs Revenue (2017-2028) & (US$ Million) Figure 64. India Erectile Dysfunction Drugs Revenue (2017-2028) & (US$ Million) Figure 65. Australia Erectile Dysfunction Drugs Revenue (2017-2028) & (US$ Million) Figure 66. China Taiwan Erectile Dysfunction Drugs Revenue (2017-2028) & (US$ Million) Figure 67. Indonesia Erectile Dysfunction Drugs Revenue (2017-2028) & (US$ Million) Figure 68. Thailand Erectile Dysfunction Drugs Revenue (2017-2028) & (US$ Million) Figure 69. Malaysia Erectile Dysfunction Drugs Revenue (2017-2028) & (US$ Million) Figure 70. Latin America Erectile Dysfunction Drugs Sales Market Share by Type (2017-2028) Figure 71. Latin America Erectile Dysfunction Drugs Revenue Market Share by Type (2017-2028) Figure 72. Latin America Erectile Dysfunction Drugs Sales Market Share by Application (2017-2028) Figure 73. Latin America Erectile Dysfunction Drugs Revenue Market Share by Application (2017-2028) Figure 74. Latin America Erectile Dysfunction Drugs Sales Share by Country (2017-2028) Figure 75. Latin America Erectile Dysfunction Drugs Revenue Share by Country (2017-2028) Figure 76. Mexico Erectile Dysfunction Drugs Revenue (2017-2028) & (US$ Million) Figure 77. Brazil Erectile Dysfunction Drugs Revenue (2017-2028) & (US$ Million) Figure 78. Argentina Erectile Dysfunction Drugs Revenue (2017-2028) & (US$ Million) Figure 79. Middle East and Africa Erectile Dysfunction Drugs Sales Market Share by Type (2017-2028) Figure 80. Middle East and Africa Erectile Dysfunction Drugs Revenue Market Share by Type (2017-2028) Figure 81. Middle East and Africa Erectile Dysfunction Drugs Sales Market Share by Application (2017-2028) Figure 82. Middle East and Africa Erectile Dysfunction Drugs Revenue Market Share by Application (2017-2028) Figure 83. Middle East and Africa Erectile Dysfunction Drugs Sales Share by Country (2017-2028) Figure 84. Middle East and Africa Erectile Dysfunction Drugs Revenue Share by Country (2017-2028) Figure 85. Turkey Erectile Dysfunction Drugs Revenue (2017-2028) & (US$ Million) Figure 86. Saudi Arabia Erectile Dysfunction Drugs Revenue (2017-2028) & (US$ Million) Figure 87. UAE Erectile Dysfunction Drugs Revenue (2017-2028) & (US$ Million) Figure 88. Erectile Dysfunction Drugs Value Chain Figure 89. Erectile Dysfunction Drugs Production Process Figure 90. Channels of Distribution Figure 91. Distributors Profiles Figure 92. Bottom-up and Top-down Approaches for This Report Figure 93. Data Triangulation Figure 94. Key Executives Interviewed

Eli Lilly Pfizer Bayer BaiYunShan General Factory S.K. Chemicals Teva Pharma Dong-A ST Metuchen Pharma Seoul Pharma CSBIO.